Klinoril is a nonsteroidal anti-inflammatory drug used to treat pain and inflammation. Its spelling can be explained using the International Phonetic Alphabet (IPA) system. The word is pronounced /klɪˈnɔːrɪl/, with stress on the second syllable. The initial "kl" is pronounced as a consonant cluster, with the "k" and "l" sounds pronounced separately. The "i" is pronounced as a short "i" sound, and the final syllable is pronounced with a short "ɪ" sound followed by an "l" sound. Overall, the spelling of Klinoril accurately represents its pronunciation.
Klinoril is a dictionary term for a nonsteroidal anti-inflammatory drug (NSAID) that is commonly used to manage and alleviate symptoms associated with various conditions such as arthritis, gout, and other inflammatory disorders. The term Klinoril specifically refers to the brand name under which the drug Sulindac is marketed.
Sulindac, the active ingredient found in Klinoril, works by inhibiting the production of substances in the body that cause inflammation, pain, and swelling. As an NSAID, it belongs to a class of medications that are frequently used to relieve pain and inflammation in individuals suffering from conditions that affect the joints, muscles, and other body parts.
Klinoril, or Sulindac, is often prescribed for its anti-inflammatory effects used to alleviate symptoms like pain and swelling associated with various forms of arthritis, including rheumatoid arthritis and osteoarthritis. Additionally, the drug is also prescribed for the management of acute gout attacks, which are characterized by severe joint pain and inflammation caused by the accumulation of uric acid crystals.
It is important to note that like all medications, Klinoril may have potential side effects and should be used according to the instructions provided by a healthcare professional or as directed on the label.